Gastrointestinal symptoms are commonly reported as adverse effects of selective serotonin
reuptake inhibitors (SSRIs), the first-line pharmacologic treatment for pediatric anxiety …

This study examined the incidence and correlates of functional gastrointestinal symptoms in
children with anxiety disorders. Participants were 6–13 year old children diagnosed with one …

Objective To determine whether children with symptoms of internalizing psychiatric
disorders have a greater prevalence of pain-predominant functional gastrointestinal …

Objectives: Pediatric functional abdominal pain is often treated with tricyclic antidepressants
(TCAs) and selective serotonin reuptake inhibitors (SSRIs). The aim is investigating …

Fluoxetine induced fecal incontinence in a 9 year old child with autistic spectrum disorder: a
case report Despite the dramatic rise in the use of selective serotonin reuptake inhibitors …

We describe the use of psychotropic medications in the treatment of functional
gastrointestinal disorders (FGIDs) in children based on available data. We address their …

OBJECTIVE: Serotonin is an important mediator of gut sensation and motility. The authors'
aim was to determine whether inadvertent gastrointestinal (GI) distress to serotonergic …

Objective: Despite lack of evidence, various pharmacological agents are judiciously used to
manage anxiety in avoidant restrictive food intake disorder (ARFID). We aimed to explore …

OBJECTIVE: To compare clinical symptoms, diagnoses, and physiological measures in
children and adolescents with recurrent abdominal pain (RAP)(n= 14), to a group with …

Objective: Generalized anxiety disorder (GAD) in children and adolescents is associated
with substantial morbidity and increases the risk of future psychopathology. However …